OpenVSafe by OpenVAERS
Search V-safe

A8G-21837-89176

3 vaccinations 14 coded responses 37 check-ins 14 free-text entries 0 call cases
Sex
—
Age at first dose
46-50
ZIP prefix
600 / IL
Registered
2021-01-01
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2020-12-30
    Dose 1 — Moderna
  2. 2021-01-01
    Registered in v-safe
  3. 2021-01-01
    Survey response — days 1–6 daily, dose 1
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain
    Free text: Axillary lymphadenopathy on same side as injection
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-01-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-06
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-13
    Survey response — day 14, dose 1
    MedDRA: Rash erythematous, Rash pruritic — Feeling: Good
    Free text: Developed 2X4cm erythematous patch on shoulder, just below injection site. Mildly pruritic. Noticed it evening of Day 7, resolved by day 9. No systemic symptoms. Allergist thought it an inflammatory reaction (messaged photo to her)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-01-21
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-01-27
    Dose 2 — Moderna
  12. 2021-01-27
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  13. 2021-01-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  14. 2021-01-29
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain
    Free text: Lymphadenopathy on same side as injection
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-01-30
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain
    Free text: Lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-01-31
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Itching
    Free text: Lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-02-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Lymphadenopathy, resolving
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-02-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-02-03
    Health check-in — day 7, dose 2
    Feeling: Good · Site: Itching · None
    Adult check-in
  20. 2021-02-10
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-02-17
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-02-24
    Survey response — day 28, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Ipsilateteral lymphadenopathy somewhat more painful than it has been. 3-4/10 in severity.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-03-03
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-03-10
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-04-28
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-07-28
    Survey response — 6 months, dose 2
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good
    Free text: Intermittent recurrence of left axillary lymphadenopathy. Lymph nodes are tender. Lasts 3-5 days and resolves spontaneously. I had this for the first time after completing vaccine series. Has recurred twice since then.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  27. 2021-10-22
    Dose 3 — Pfizer-BioNTech
  28. 2021-10-24
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness
    Free text: Left axillary lymphadenopathy
    MedDRA releases: 2024-11 · check-in free text available
  29. 2021-10-25
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Fatigue or tiredness
    Free text: Left axillary lymphadenopathy
    MedDRA releases: 2024-11 · check-in free text available
  30. 2021-10-26
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Left axillary lymphadenopathy
    MedDRA releases: 2024-11 · check-in free text available
  31. 2021-10-27
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Left axillary lymphadenopathy
    MedDRA releases: 2024-11 · check-in free text available
  32. 2021-10-28
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Left axillary lymphadenopathy
    MedDRA releases: 2024-11 · check-in free text available
  33. 2021-10-29
    Survey response — day 7, dose 3
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Left axillary lymphadenopathy
    MedDRA releases: 2024-11 · check-in free text available
  34. 2021-11-05
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  35. 2021-11-14
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  36. 2021-11-19
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  37. 2021-11-26
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  38. 2021-12-05
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  39. 2022-01-21
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  40. 2022-04-24
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  41. 2022-10-22
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-30Moderna
22021-01-27Moderna
32021-10-22Pfizer-BioNTech No

Free text

Release 1 — days 1–6 daily, dose 1

2021-01-01

Systemic reaction (other): Axillary lymphadenopathy on same side as injection

Release 1 — day 14, dose 1

2021-01-13

Symptoms: Developed 2X4cm erythematous patch on shoulder, just below injection site. Mildly pruritic. Noticed it evening of Day 7, resolved by day 9. No systemic symptoms. Allergist thought it an inflammatory reaction (messaged photo to her)

Release 3 — days 1–6 daily, dose 2

2021-01-29

Systemic reaction (other): Lymphadenopathy on same side as injection

2021-01-30

Systemic reaction (other): Lymphadenopathy

2021-01-31

Systemic reaction (other): Lymphadenopathy

2021-02-01

Systemic reaction (other): Lymphadenopathy, resolving

Release 4 — day 28, dose 2

2021-02-24

Symptoms: Ipsilateteral lymphadenopathy somewhat more painful than it has been. 3-4/10 in severity.

Release 9 — 6 months, dose 2

2021-07-28

Symptoms: Intermittent recurrence of left axillary lymphadenopathy. Lymph nodes are tender. Lasts 3-5 days and resolves spontaneously. I had this for the first time after completing vaccine series. Has recurred twice since then.

Release 10 — days 1–6 daily, dose 3

2021-10-24

Systemic reaction (other): Left axillary lymphadenopathy

2021-10-25

Systemic reaction (other): Left axillary lymphadenopathy

2021-10-26

Systemic reaction (other): Left axillary lymphadenopathy

2021-10-27

Systemic reaction (other): Left axillary lymphadenopathy

2021-10-28

Systemic reaction (other): Left axillary lymphadenopathy

Release 10 — day 7, dose 3

2021-10-29

Systemic reaction (other): Left axillary lymphadenopathy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDLymph node pain ✓ · ✓
SDLymphadenopathy ✓ ✓ ✓
SDRash erythematous ✓ ✓ ✓
SDRash pruritic ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release